The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.

Applied Biochemistry and Biotechnology is a leading journal published by Springer, dedicated to advancing research in the interdisciplinary fields of biochemistry, biotechnology, and applied microbiology. Established in 1981, this peer-reviewed journal covers a wide range of topics that encompass innovative techniques, methodologies, and applications of biochemistry and biotechnology in medicine, environmental engineering, and molecular biology. With a Q2 ranking in several categories and an increasing impact factor, the journal demonstrates significant influence and credibility within the scientific community. While traditionally subscription-based, the journal offers avenues for open access through selective agreements, making high-quality research accessible to a broader audience. Researchers, professionals, and students alike will find Applied Biochemistry and Biotechnology to be an invaluable resource for the latest developments and applications in biochemistry and its related fields, aiding in the quest for sustainable solutions and novel biotechnological advancements.

MOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.

JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

METABOLIC ENGINEERING, published by Academic Press Inc. Elsevier Science, is a renowned journal in the fields of Applied Microbiology, Biotechnology, and Bioengineering. With an impressive impact factor and ranking in the top quartile (Q1) across its specialized categories for 2023, this journal facilitates the dissemination of cutting-edge research focused on metabolic pathways and engineering methods that optimize biological systems for various applications. Since its inception in 1999, it has established itself as a critical resource for academics and industry professionals seeking innovative solutions to complex biosynthetic challenges. The journal invites original research, reviews, and technical notes that advance the understanding and utilization of metabolic processes; thus, it plays a pivotal role in bridging laboratory discoveries with practical applications. Although the journal does not offer open access, its high visibility and rigorous peer-review process ensure that it remains a vital source of knowledge and inspiration for researchers and students alike.

Journal of Genetic Engineering and Biotechnology, published by Elsevier Science Inc, is a prestigious open-access journal that stands at the forefront of research in the fields of biotechnology and genetics. Since its inception in 2011, the journal has provided a platform for cutting-edge studies that explore the complexities and innovations within genetic engineering and its applications in biotechnology. With a commendable Impact Factor and recognized as a Q2 journal in both biotechnology and genetics as per 2023 categorization, it ranks well within Scopus, evidencing its influence in the scientific community. Researchers and professionals accessing articles published in this journal benefit from timely contributions that bridge theoretical and practical aspects of genetic technologies. By fostering a collaborative environment, the Journal of Genetic Engineering and Biotechnology aims to promote advancements that drive science forward, making it an essential resource for students, academics, and industry practitioners alike. For those interested in making their mark in these rapidly evolving fields, this journal offers unparalleled access to high-quality, peer-reviewed research.

CRITICAL REVIEWS IN BIOTECHNOLOGY, published by Taylor & Francis Ltd, stands as a leading journal in the field of biotechnology, consistently recognized for its rigorous peer-reviewed articles that impact the disciplines of Applied Microbiology, Biotechnology, and Medicine. With an impressive Q1 ranking in these categories and a significant influence reflected in its Scopus rankings—placing it within the top 5% of Applied Microbiology and the top 4% of Biotechnology journals—the journal serves as an essential resource for researchers, professionals, and students alike. Launched in 1983 and extending its coverage to encompass groundbreaking findings through 2024, it provides a rich forum for insightful reviews and innovative research that propel the field forward. Though not an Open Access journal, CRITICAL REVIEWS IN BIOTECHNOLOGY remains a vital point of reference for ongoing developments, critical analyses, and emerging trends, making it indispensable for those seeking to stay at the forefront of biotechnological advancements.

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, published by Oxford University Press, is a vital resource for researchers and professionals actively engaged in the fields of applied microbiology, biotechnology, and bioengineering. With an ISSN of 1367-5435 and E-ISSN of 1476-5535, this journal has established itself as a leading platform for disseminating innovative research findings and advancing knowledge in industrial microbiology since its inception in 1996. As of 2023, it is classified in the Q2 quartile across multiple categories including Applied Microbiology and Biotechnology, Bioengineering, and Medicine, underscoring its significance in the academic community. Notably, it ranks 26th of 127 in Applied Microbiology and Biotechnology, placing it in the 79th percentile, indicative of its high impact and influence. Although it does not currently offer Open Access, it remains a key outlet for high-quality scholarly articles that align with the objectives of improving industrial practices through biotechnological applications. For those interested in the latest developments and methodologies within the realm of applied microbiology and biotechnology, this journal serves as an indispensable reference.